The Rescue of miR-148a Expression in Pancreatic Cancer: An Inappropriate Therapeutic Tool

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Delpu, Yannick ^a,b   Lulka, Hubert ^a,b   Sicard, Flavie ^a,b   Saint Laurent, Nathalie ^b,d   Lopez, Frédéric ^b,d   Hanoun, Naïma ^a,b   Buscail, Louis ^a,b,c   Cordelier, Pierre ^a,b   Torrisani, Jérôme ^a,b  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CHU RANGUEIL   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; MICRORNA; MICRORNA 148A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA METHYLATION; FLOW CYTOMETRY; GENE SEQUENCE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MICROENVIRONMENT; MOUSE; NONHUMAN; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR GROWTH; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; MICE; MICRORNAS; PANCREATIC NEOPLASMS; PROTEOME; PROTEOMICS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873208217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055513     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Hidalgo M, (2010) Pancreatic cancer. N Engl J Med 362: 1605-1617.
3. Ghaneh P, Costello E, Neoptolemos JP, (2007) Biology and management of pancreatic cancer. Gut 56: 1134-1152.
4. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M, (2004) Pancreatic cancer. Lancet 363: 1049-1057.
5. Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, et al. (2011) Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis. Curr Genomics 12: 15-24.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, et al. (2010) The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 56: 1107-1118 doi:10.1373/clinchem.2010.144709.
8. Zheng B, Liang L, Wang C, Huang S, Cao X, et al. (2011) MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17: 7574-7583.
9. Hummel R, Watson DI, Smith C, Kist J, Michael MZ, et al. (2011) Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J Gastrointest Surg 15: 429-438.
10. Zhang H, Li Y, Huang Q, Ren X, Hu H, et al. (2011) MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ 18: 1702-1710.
11. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105: 13556-13561.
12. Liu N, Furukawa T, Kobari M, Tsao MS, (1998) Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol 153: 263-269.
13. Lee KM, Nguyen C, Ulrich AB, Pour PM, Ouellette MM, (2003) Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochem Biophys Res Commun 301: 1038-1044.
14. Hanoun N, Bureau C, Diab T, Gayet O, Dusetti N, et al. (2010) The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions. J Hepatol 53: 880-888.
15. Torrisani J, Bournet B, Du Rieu MC, Bouisson M, Souque A, et al. (2009) let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther 20: 831-844.
16. Kutanzi KR, Yurchenko OV, Beland FA, Checkhun VF, Pogribny IP, (2011) MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics 2: 171-185 doi:10.1007/s13148-011-0040-8.
17. Chung E, Yamashita H, Au P, Tannous BA, Fukumura D, et al. (2009) Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS One 4: e8316.
18. Zhou X, Zhao F, Wang Z-N, Song Y-X, Chang H, et al. (2012) Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep 27: 447-454.
19. Fujita Y, Kojima K, Ohhashi R, Hamada N, Nozawa Y, et al. (2010) MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem 285: 19076-19084.
20. Liffers S-T, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, et al. (2011) MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 91: 1472-1479 doi:10.1038/labinvest.2011.99.
21. Yuan K, Lian Z, Sun B, Clayton MM, Ng IOL, et al. (2012) Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS ONE 7: e35331.
22. Chen Y, Song Y, Wang Z, Yue Z, Xu H, et al. (2010) Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 14: 1170-1179.
23. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, et al. (2009) microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 34: 537-542.
24. Guo S-L, Peng Z, Yang X, Fan K-J, Ye H, et al. (2011) miR-148a Promoted Cell Proliferation by Targeting p27 in Gastric Cancer Cells. Int J Biol Sci 7: 567-574.
25. Duursma AM, Kedde M, Schrier M, Le Sage C, Agami R, (2008) miR-148 targets human DNMT3b protein coding region. Rna 14: 872-877.
26. Braconi C, Huang N, Patel T, (2010) MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51: 881-890.
27. Schramedei K, Mörbt N, Pfeifer G, Läuter J, Rosolowski M, et al. (2011) MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 30: 2975-2985.
28. Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, et al. (2009) MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer 45: 3104-3118.